30.8.21 Rua Bioscience has made its first financial year report to NZX since its oversubscribed $20m public offer in October 2020. Since then, it has been on building solid foundations for growth – developing the partnerships, places, processes, and people it needs to create a sustainable medicinal cannabis business model. Rua has also been preparing […]